Find the Perfect Plan for Your Investment Journey
Latest price
52 Week Range
$11.66 - $28.68
Next Earnings Date
May 08 2025
Next Earnings Date
May 08 2025
Latest price
Market Cap | $1.80B |
EV | $1.77B |
Shares Outstanding | 121.91M |
Beta | 2.01 |
Analyst Rating | OUTPERFORM |
Analyst Target Price | $23.50 |
P/E 2025E | 44.04x |
P/Revenue 2025E | 2.04x |
Revenue | 12.60% |
EPS | - |
Operating Cash Flow | - |
Free Cash Flow | - |
Revenue | 14.40% |
EPS | 36.60% |
Operating Cash Flow | - |
Free Cash Flow | 23.90% |
Gross Margin 2025E | 55.29% |
Net Profit Margin 2025E | 2.61% |
ROE 2025E | 8.32% |
ROCE 2024 | -6.35% |
DPS 2025E | $0.00 |
Payout Ratio 2025E | 0.00% |
Div. Yield 2025E | 0.00% |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
Warby Parker Inc.
WRBY
Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Data Unavailable
Employees
2,999
Website
www.warbyparker.comIPO Date
2021-09-29
Headquarters
233 Spring Street, 6th Floor East, New York, New York, 10013, United States
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved